Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatectomy After Conversion Therapy for Initially Unresectable HCC: What is the Difference?
Laihui Luo, Yongzhu He, Guoqing Zhu, et al.
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 1353-1368
Open Access | Times Cited: 23

Showing 23 citing articles:

Watch-and-Wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma：a propensity score-matching comparative study
Binkui Li, Chenwei Wang, Wei He, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 14
Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities
Ming‐Da Wang, Xuejun Xu, Ke‐Chun Wang, et al.
Cancer Science (2024) Vol. 115, Iss. 7, pp. 2159-2169
Open Access | Times Cited: 12
Comparison of survival benefit and safety between surgery following conversion therapy versus surgery alone in patients with surgically resectable hepatocellular carcinoma at CNLC IIb/IIIa stage: a propensity score matching study
Zi‐Feng Ma, Zhiyu Xiao, Pengfei Yin, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 7
Prognosis prediction and risk stratification of transarterial chemoembolization or intraarterial chemotherapy for unresectable hepatocellular carcinoma based on machine learning
Wendao Liu, Ran Wei, Junwei Chen, et al.
European Radiology (2024) Vol. 34, Iss. 8, pp. 5094-5107
Open Access | Times Cited: 6
Safety and Survival Outcomes of Liver Resection following Triple Combination Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma
Yin Long, Jue Huang, Jianguo Liao, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5878-5878
Open Access | Times Cited: 12
What Is the Role of Minimally Invasive Liver Surgery in Treating Patients with Hepatocellular Carcinoma on Cirrhosis?
Alessandro Vitale, Roberta Angelico, Bruno Sensi, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 966-966
Open Access | Times Cited: 4
Development of a Nomogram for Prognostic Prediction of Large Hepatocellular Carcinoma With HBV After TACE Combined Conversion Therapy
Wei Xu, Xia Ding, Yan Xu, et al.
Hepatic Medicine Evidence and Research (2025) Vol. Volume 17, pp. 1-12
Open Access
High Plasma Alpha‐Fetoprotein Level Is Associated With Early Postoperative Complications in Patients With Hepatocellular Carcinoma in Southern Vietnam During 2018–2023: A Cross‐Sectional Study
Long Huynh Thanh, Nguyễn Mạnh Khiêm, Hung Nguyen Quang
Health Science Reports (2025) Vol. 8, Iss. 4
Open Access
Clinical efficacy of precision liver resection for primary liver cancer
Yunhao Zhang
American Journal of Translational Research (2024) Vol. 16, Iss. 3, pp. 897-904
Open Access | Times Cited: 2
Conversion therapy of a giant hepatocellular carcinoma with portal vein thrombus and inferior vena cava thrombus: A case report and review of literature
Wenjie Song, Jian Xu, Ye Nie, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 16, pp. 2847-2855
Open Access | Times Cited: 2
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients
Kongying Lin, Zhi-Wen Lin, Qing-Jing Chen, et al.
Hepatology International (2023) Vol. 17, Iss. 6, pp. 1477-1489
Closed Access | Times Cited: 6
Conversion surgery for initially unresectable hepatocellular carcinoma using lenvatinib combined with TACE plus PD-1 inhibitor: A real-world observational study
Xingzhi Li, Xiaobo Wang, Tao Bai, et al.
Digestive and Liver Disease (2023) Vol. 56, Iss. 6, pp. 1078-1086
Closed Access | Times Cited: 5
Clinical Complete Response After Conversion Therapy for Unresectable Hepatocellular Carcinoma: Is Salvage Hepatectomy Necessary?
Jiayi Wu, Jiayi Wu, De-Yi Liu, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 2161-2171
Open Access | Times Cited: 4
Multiparametric MRI based deep learning model for prediction of early recurrence of hepatocellular carcinoma after SR following TACE
Hongyu Wang, Jinwei Li, Yu-Shu Ouyang, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 10
Open Access | Times Cited: 1
Expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition)
Haowen Tang, Wenwen Zhang, Junning Cao, et al.
BioScience Trends (2024) Vol. 18, Iss. 6, pp. 505-524
Open Access | Times Cited: 1
Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma
Alexander H. Shannon, Ashish Manne, D.A. Diaz Pardo, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Conversion therapy for initially unresectable hepatocellular carcinoma: Current status and prospects
Yanan Ma, Xuemei Jiang, Hui Liu, et al.
BioScience Trends (2023) Vol. 17, Iss. 6, pp. 415-426
Open Access | Times Cited: 3
Advances in systemic therapy leading to conversion surgery for advanced hepatocellular carcinoma
Hiroyuki Hakoda, Akihiko Ichida, Kiyoshi Hasegawa
BioScience Trends (2024) Vol. 18, Iss. 6, pp. 525-534
Open Access
A systematic review and meta-analysis of blood transfusion rates during liver resection by country
S.-H. Kim, Yun Kyung Jung, Kyeong Geun Lee, et al.
Annals of Surgical Treatment and Research (2023) Vol. 105, Iss. 6, pp. 404-404
Open Access | Times Cited: 1
The combination of ALPPS, interventional hepatoma therapy, targeted therapy, and immunotherapy: A novel conversion therapy model for unresectable HCC
Chen Zhu, Haiyang Hu, Xingyu Chen, et al.
Research Square (Research Square) (2024)
Closed Access
Non-surgery strategy versus hepatectomy in hepatocellular carcinoma patients with complete response after conversion therapy: a meta-analysis
Jie Wang, Yanfeng Hu, Lingyi Zhou, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access
Conversion therapy of a giant HCC with portal vein thrombus and inferior vena cava tumor thrombus
Wenjie Song, Jian Xu, Ye Nie, et al.
Research Square (Research Square) (2023)
Open Access
Hepatic Artery Infusion Chemotherapy Sequential Hepatic Artery Embolization Combined with Operation in the Treatment of Recurrent Massive Hepatocellular Carcinoma Achieved Pathological Complete Response: A Case Report
Junjie Chen, Xiwen Liao, Yining Wu, et al.
Pharmacogenomics and Personalized Medicine (2023) Vol. Volume 16, pp. 949-958
Open Access
Page 1

Scroll to top